| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5927948 | American Heart Journal | 2016 | 10 Pages |
Abstract
RenalGuard therapy is safe and effective in reaching high UFR. Mean intraprocedural UFR â¥450 mL/h should be the target for optimal CI-AKI prevention.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Carlo MD, PhD, Gabriella MD, Michael MD, Francesca PhD, Amelia MD, Bruno MD, Giuseppe PhD, Carmine PhD, Elvira PhD, Gerolama MD, PhD,